Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding.

Source:http://linkedlifedata.com/resource/pubmed/id/14698157

Bioorg. Med. Chem. Lett. 2004 Jan 19 14 2 351-5

Download in:

View as

General Info

PMID
14698157